{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:54:17Z","timestamp":1781646857855,"version":"3.54.5"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>TANGO2 deficiency is a rare inherited metabolic disorder characterized by recurrent metabolic crises, rhabdomyolysis, arrhythmias, and encephalopathy. Recent studies suggest that TANGO2 functions as a mitochondrial lipid-acyl-CoA handling protein. Nonetheless, the cerebral metabolic abnormalities underlying neurological deterioration remain elusive. In this study, we present the first longitudinal evaluation of brain metabolism using proton magnetic resonance spectroscopy (MRS) before and after vitamin therapy, during the acute, subacute, and post-treatment phases, highlighting improved clinical manifestations following treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We longitudinally evaluated cerebral metabolites using MRS during the acute, subacute, and post-treatment phases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A 2-year-old boy with genetically confirmed TANGO2 deficiency presented with a metabolic crisis, status epilepticus, and rhabdomyolysis (CK peak, 282,695\u2009U\/L). Despite the absence of structural abnormalities on the magnetic resonance imaging conducted on day 2, MRS revealed markedly increased glutamate (Glu; 11.51\u2009mM; reference: 6.70\u2009\u00b1\u20090.59) with normal glutamine (Gln). On day 50, despite clinical stabilization, Glu levels remained abnormally high (9.29\u2009mM), indicating a persistent dysfunction of the cerebral Glu\u2013Gln cycle. Upon initiation of vitamin supplementation, including that of all eight B vitamins (i.e. B\u2081, B\u2082, B\u2083, B\u2085, B\u2086, B\u2087, B\u2089, and B\u2081\u2082) at the age of 3, no further crises occurred. Follow-up MRS at the age of 4 demonstrated Glu normalization (7.20\u2009mM; reference: 6.50\u2009\u00b1\u20090.70).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case provides pioneering in vivo evidence of sustained cerebral Glu accumulation in a patient with TANGO2 deficiency along with improvement after metabolic therapy. Our results suggest that the impairment of energy-dependent Glu\u2013Gln cycling and astrocytic Glu clearance might constitute a potential mechanism underlying neurological vulnerability in TANGO2 deficiency. Longitudinal MRS may allow metabolic instability and treatment responsiveness monitoring in this disorder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04338-x","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T16:58:08Z","timestamp":1774889888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Persistent glutamate increase in TANGO2 deficiency with normalization after vitamin supplementation: first documentation by MR spectroscopy"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3110-4836","authenticated-orcid":false,"given":"Taku","family":"Omata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Shimizu-Motohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"4338_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ajhg.2015.12.008","volume":"98","author":"SR Lalani","year":"2016","unstructured":"Lalani SR, Liu P, Rosenfeld JA, Watkin LB, Chiang T, Leduc MS, et al. Recurrent muscle weakness with rhabdomyolysis, metabolic crises, and cardiac arrhythmia due to bi-allelic TANGO2 mutations. Am J Hum Genet. 2016;98:347\u201357. https:\/\/doi.org\/10.1016\/j.ajhg.2015.12.008","journal-title":"Am J Hum Genet"},{"key":"4338_CR2","doi-asserted-by":"publisher","first-page":"15824","DOI":"10.1038\/ncomms15824","volume":"8","author":"LS Kremer","year":"2017","unstructured":"Kremer LS, Bader DM, Mertes C, Kopajtich R, Pichler G, Iuso A, et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat Commun. 2017;8:15824. https:\/\/doi.org\/10.1038\/ncomms15824","journal-title":"Nat Commun"},{"key":"4338_CR3","doi-asserted-by":"publisher","first-page":"100352","DOI":"10.1016\/j.gim.2022.11.020","volume":"25","author":"CY Miyake","year":"2023","unstructured":"Miyake CY, Lay EJ, Soler-Alfonso C, Glinton KE, Houck KM, Tosur M, et al. Natural history of TANGO2 deficiency disorder: baseline assessment of 73 patients. Genet Med. 2023;25:100352. https:\/\/doi.org\/10.1016\/j.gim.2022.11.020","journal-title":"Genet Med"},{"key":"4338_CR4","doi-asserted-by":"publisher","unstructured":"Mukhtiar K, Ibrahim S, Khalid QUA. TANGO-2: a rare genetic condition with severe clinical presentation of encephalopathy, rhabdomyolysis, and cardiac rhythm disorders in 2 children. J Child Neurol. 2025;40:558\u201362. https:\/\/doi.org\/10.1177\/08830738251328404","DOI":"10.1177\/08830738251328404"},{"key":"4338_CR5","doi-asserted-by":"publisher","unstructured":"Mackenzie SJ. Mitochondrial mayhem: disrupting conserved N-terminal motifs in TANGO2 impacts its localization and function. J Cell Biol. 2025;224:e202503010. https:\/\/doi.org\/10.1083\/jcb.202503010","DOI":"10.1083\/jcb.202503010"},{"key":"4338_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/jimd.12585","volume":"46","author":"SE Sandkuhler","year":"2023","unstructured":"Sandkuhler SE, Zhang L, Meisner JK, Ghaloul-Gonzalez L, Beach CM, Harris D, et al. B-complex vitamins for patients with TANGO2-deficiency disorder. J Inherit Metab Dis. 2023;46:161\u201362. https:\/\/doi.org\/10.1002\/jimd.12585","journal-title":"J Inherit Metab Dis"},{"key":"4338_CR7","doi-asserted-by":"publisher","unstructured":"Lujan AL, Foresti O, Wojnacki J, Bigliani G, Brouwers N, Pena MJ, et al. TANGO2 is an acyl-CoA binding protein. J Cell Biol. 2025;224:e202410001. https:\/\/doi.org\/10.1083\/jcb.202410001","DOI":"10.1083\/jcb.202410001"},{"key":"4338_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00234-015-1573-x","volume":"57","author":"JI Takanashi","year":"2015","unstructured":"Takanashi JI, Mizuguchi M, Terai M, Barkovich AJ. Disrupted glutamate-glutamine cycle in acute encephalopathy with biphasic seizures and late reduced diffusion. Neuroradiology. 2015;57:1163\u201368. https:\/\/doi.org\/10.1007\/s00234-015-1573-x","journal-title":"Neuroradiology"},{"key":"4338_CR9","doi-asserted-by":"publisher","first-page":"104442","DOI":"10.1016\/j.braindev.2025.104442","volume":"47","author":"R Sugiyama","year":"2025","unstructured":"Sugiyama R, Shimizu-Motohashi Y, Sakata Y, Omata T, Takanashi JI, Furukawa S, et al. Muscle and thyroid manifestations in TANGO2 deficiency disorder: a case study of novel biallelic variants. Brain Dev. 2025;47:104442. https:\/\/doi.org\/10.1016\/j.braindev.2025.104442","journal-title":"Brain Dev"},{"key":"4338_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.braindev.2009.02.012","volume":"31","author":"J Takanashi","year":"2009","unstructured":"Takanashi J. Two newly proposed infectious encephalitis\/encephalopathy syndromes. Brain Dev. 2009;31:521\u201328. https:\/\/doi.org\/10.1016\/j.braindev.2009.02.012","journal-title":"Brain Dev"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04338-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:11:22Z","timestamp":1781644282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04338-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4338"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04338-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Tokyo Women\u2019s Medical University Institutional Review Board (approval number: 3535\u2009R, 2023\u20130068).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for the publication of the clinical information and MRI\/MRS images was obtained from the family of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}